Cargando…

Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors

With the umbrella term ‘neurodevelopmental disorders’ (NDDs) we refer to a plethora of congenital pathological conditions generally connected with cognitive, social behavior, and sensory/motor alterations. Among the possible causes, gestational and perinatal insults have been demonstrated to interfe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boccazzi, Marta, Raffaele, Stefano, Zanettin, Thomas, Abbracchio, Maria P., Fumagalli, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216121/ https://www.ncbi.nlm.nih.gov/pubmed/37238724 http://dx.doi.org/10.3390/biom13050856

Ejemplares similares

Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis?
por: Lecca, Davide, et al.
Publicado: (2021)

Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
por: Raffaele, Stefano, et al.
Publicado: (2021)

Not only myelination: the immune-inflammatory functions of oligodendrocytes
por: Boccazzi, Marta, et al.
Publicado: (2022)

In Memoriam Geoffrey Burnstock: Creator of Purinergic Signaling
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation
por: Sebastián-Serrano, Álvaro, et al.
Publicado: (2016)

Cardiomyocyte death induced by ischaemic/hypoxic stress is differentially affected by distinct purinergic P2 receptors
por: Cosentino, Simona, et al.
Publicado: (2012)

Purinergic transmission in brain tumors and its impact on drug development
por: Abbracchio, Maria, et al.
Publicado: (2015)

GPR17: Molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors
por: Parravicini, Chiara, et al.
Publicado: (2008)

Roles of P2 receptors in glial cells: focus on astrocytes
por: Abbracchio, Maria P., et al.
Publicado: (2006)

Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
por: Bonfanti, Elisabetta, et al.
Publicado: (2020)

Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways
por: Procopio, Maria Cristina, et al.
Publicado: (2021)

Novel in vitro Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System
por: Marangon, Davide, et al.
Publicado: (2021)

Control of Gut Inflammation by Modulation of Purinergic Signaling
por: Vuerich, Marta, et al.
Publicado: (2020)

Glial Purinergic Signals and Psychiatric Disorders
por: Koizumi, Schuichi
Publicado: (2022)

Alterations of Purinergic Receptors Levels and Their Involvement in the Glial Cell Morphology in a Pre-Clinical Model of Autism Spectrum Disorders
por: Babiec, Lidia, et al.
Publicado: (2023)

Eosinophils and Purinergic Signaling in Health and Disease
por: Ferrari, Davide, et al.
Publicado: (2020)

Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022)

Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair
por: Marangon, Davide, et al.
Publicado: (2020)

The Role of Microglial Purinergic Receptors in Pain Signaling
por: Tozaki-Saitoh, Hidetoshi, et al.
Publicado: (2022)

New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders
por: Majumder, Paromita, et al.
Publicado: (2007)

Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
por: Lee, Jieon, et al.
Publicado: (2021)

Focus on autism and other neurodevelopmental disorders
por: Ryabinin, Andrey E.
Publicado: (2021)

Purine and purinergic receptors
por: Burnstock, Geoffrey
Publicado: (2018)

Purinergic signalling in bone
por: Rumney, Robin M. H., et al.
Publicado: (2012)

Purinergic signalling and diabetes
por: Burnstock, Geoffrey, et al.
Publicado: (2013)

Purinergic Signaling in Bone
por: Jørgensen, Niklas Rye, et al.
Publicado: (2013)

Purinergic signalling in neuroregeneration
por: Burnstock, Geoffrey
Publicado: (2015)

Purinergic Signaling in Spermatogenesis
por: Mundt, Nadine, et al.
Publicado: (2022)

Purinergic Signaling in Neuroinflammation
por: Aminin, Dmitry, et al.
Publicado: (2021)

Purinergic Signalling in the Cochlea
por: Vlajkovic, Srdjan M., et al.
Publicado: (2022)

Purinergic receptor mediated calcium signalling in urothelial cells
por: Chess-Williams, Russell, et al.
Publicado: (2019)

P2 purinergic receptor modulation of cytokine production
por: Gabel, Christopher A.
Publicado: (2007)

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021)

P2 purinergic receptor dysregulation in urologic disease
por: Maynard, Janielle P., et al.
Publicado: (2022)

Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022)

Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases
por: Fumagalli, Marta, et al.
Publicado: (2017)

Purinergic Receptors Crosstalk with CCR5 to Amplify Ca(2+) Signaling
por: Horioka, Mizuho, et al.
Publicado: (2020)

Using antibodies against P2Y and P2X receptors in purinergic signaling research
por: Brass, Dovrat, et al.
Publicado: (2011)

Purinergic Receptors in Adipose Tissue As Potential Targets in Metabolic Disorders
por: Tozzi, Marco, et al.
Publicado: (2017)

P1 receptors and cytokine secretion
por: Abbracchio, Maria P., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_v9ivka3f2iopekvjh45aq2hfbp